title: Treatment planning evaluation and optimization should be biologically and not dose/volume based.
authors.affiliation: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065 (Tel: 212-639-8413; E-mail: deasyj@mskcc.org).
authors.forename: Joseph O
authors.initials: JO
authors.lastname: Deasy
authors.affiliation: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905 (Tel: 507-293-4577; E-mail: Mayo.Charles@mayo.edu).
authors.forename: Charles S
authors.initials: CS
authors.lastname: Mayo
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy; D011336:Probability; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000517:prevention & control; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D016896:Treatment Outcome